Expression of miRNA-25 in young and old lung adenocarcinoma

BACKGROUND: An appropriate personalized molecular testing ensures the most efficacious treatment in lung cancer. It is still controversial whether younger lung adenocarcinoma (LUAD) patients have different molecular features compared with their older counterparts. MicroRNAs have been involved in lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Boldrini, Laura, Giordano, Mirella, Melfi, Franca, Lucchi, Marco, Fontanini, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772505/
https://www.ncbi.nlm.nih.gov/pubmed/35126595
http://dx.doi.org/10.4103/jrms.JRMS_830_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772505/
https://www.ncbi.nlm.nih.gov/pubmed/35126595
http://dx.doi.org/10.4103/jrms.JRMS_830_19

Ejemplares similares